A Experimental Study on Treatment of Lung Cancer with Bacillus Calmette-Guerin Polysaccharides Nucleic Acid Combined with Chemotherapy
- VernacularTitle:卡介菌多糖核酸与化疗药物联合治疗肺癌的实验研究
- Author:
Jianxin LIU
;
Longyu JIN
;
Zhao HONG
- Publication Type:Journal Article
- Keywords:
Lung cancer;
Chemotherapy;
BCG-PSN;
Immunity;
Mouse
- From:
Journal of Chinese Physician
2001;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the mechanism of treatment of lung cancer with Bacillus Calmette-Guerin Polysaccharides nucleic acid (BCG-PSN) combined with Cyclophosphamide(Cy). Methods 130 mice were divided into three groups (A,B and C groups). Gruop A was further divided into four subgroups . Subgroup A-1 was given normal saline orally 0.25mg/10g?d -1 ; Subgroup A-2 was given levomisole PO. 0.25mg/10g?d -1 ; Subgroup A-3 was given BCG-PSN PO.0.325mg/10g?d -1 and subgroup A-4 was given BCG-PSN by intra-abdominal injection 0.25mg/10g?d -1 . Group B was given identical drugs with group A, after fifth day given 20% sheep red blood cell 0.2ml by intra-abdominal injection for five days . Gruop C divided into five subgroups;Subgroup C1-4 were given same drugs with group A,then given 0.4% Cy by subcutaneous injection 0.25mg/10g?d -1 from fifth day to tenth day.Subgroup C-5 was normal contral group, was given normal saline 0.25mg/10g?d -1 PO and subcutaneous injection 0.25mg/10g?d -1 .Results Oral administration alone or intra-abdominal injection in subgroup A-4 obviously enhanced the phagocytosis of macrophages.The subcutaneous injection of Cy could obviously decrease anti-tumour immunity, including activity of interleukin-2 (IL-2),natural killer(NK) cell, lyphocyte trasformation, and macrophages phagocytosis. BCG-PSN could increase and rehabilitate above anti-tumour immunological function. Conclusions Combinative treatment of BCG-PSN with Cy could remarkable enhance the immunocompetence.This experiment may provide a theoretical evidence for BCG-PSN combined with chemotheapeutic agents applied to treat the lung cancer.